Key Market Segments
By Product Type
-
Passive Approximators
-
Active Approximators
-
External Hemostatic Devices
By Access Type
-
Femoral
-
Radial
-
Others
By Procedure
-
Interventional Cardiology
-
Interventional Radiology
-
Endovascular Surgery
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Vascular Closure Devices Market in 2025 with approximately 42.67% of global revenues, led by the United States the world's highest-volume interventional cardiovascular procedure market supported by the most favourable VCD reimbursement policies, rapid structural heart programme expansion, and the commercial presence of leading VCD innovators including Abbott, Medtronic, Teleflex, and Haemonetics.
Active Approximators encompassing suture-mediated and clip-based closure systems dominated the market in 2025 with approximately 54% of global revenue, driven by their superior hemostasis reliability, broad clinical applicability across arterial access sizes, and extensive procedural adoption in PCI, TAVR, and peripheral vascular interventions.
Rising global interventional cardiovascular procedure volumes driven by escalating CVD burden, the rapid expansion of structural heart interventions including TAVR and LAAC creating premium large-bore VCD demand, and the clinical and economic superiority of device-based closure over manual compression enabling same-day discharge protocols are the primary structural growth drivers through 2035.
The Vascular Closure Devices Market was valued at USD 1.92 billion in 2025.
The Vascular Closure Devices Market is expected to grow at a CAGR of 7.85% from 2026 to 2035.
Get in Touch
